ResQ Pharma, Inc
ResQ Pharma, Inc
  • Home
  • About Us
  • Background
  • Target Indications
  • History
  • Contact
  • More
    • Home
    • About Us
    • Background
    • Target Indications
    • History
    • Contact
  • Home
  • About Us
  • Background
  • Target Indications
  • History
  • Contact

A brief bibliography of LipidRescue in treating IRI

Siamak Rahman, M.D., Jingyuan Li, M.D., Ph.D., Jean Chrisostome Bopassa, Ph.D., Soban Umar, M.D., Ph.D., Andrea Iorga, B.Sc., Parisa Partownavid, M.D., Mansoureh Eghbali, Ph.D. Phosphorylation of GSK-3β Mediates Intralipid-induced Cardioprotection against Ischemia/Reperfusion Injury. Anesthesiology. August 2011: 115(2):242–253

Find out more

Zaugg M, Lou PH, Lucchinetti E, Gandhi M, Clanachan AS. Postconditioning with Intralipid emulsion protects against reperfusion injury in post-infarct remodeled rat hearts by activation of ROS-Akt/Erk signaling.Transl Res. 2017 Aug;186:36-51.

Find out more

Soban Umar, M.D., Ph.D., Jingyuan Li, M.D., Ph.D., Kyle Hannabass, M.D., Mylene Vaillancourt, M.Sc., Christine M. Cunningham, B.S., Shayan Moazeni, B.S., Aman Mahajan, M.D., Ph.D., Mansoureh Eghbali, Ph.D. Free Fatty Acid Receptor G-protein–coupled Receptor 40 Mediates Lipid Emulsion-induced Cardioprotection. Anesthesiology. July 2018: 129(1):154–162

Find out more

Michael R. Fettiplace, M.S., Katarzyna Kowal, B.S., Richard Ripper, C.V.T., Alexandria Young, B.S., Kinga Lis, B.S., Israel Rubinstein, M.D., Marcelo Bonini, Ph.D., Richard Minshall, Ph.D., Guy Weinberg, M.D. Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion Anesthesiology. February 2016: 124(2):428–442 

Find out more

Van de Velde M, Wouters PF, Rolf N, Van Aken H, Flameng W, Vandermeersch E. Long-chain triglycerides improve recovery from myocardial stunning in conscious dogs. Cardiovasc Res. 1996 Dec;32(6):1008-15. 

Find out more

  

LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA. 

LipidRescue® is a proposed proprietary name that is subject to FDA approval. 


Website designed by JDW

Copyright © 2021 ResQ Pharma, Inc - All Rights Reserved.


Powered by GoDaddy